206 related articles for article (PubMed ID: 31578370)
1. Polymorphisms in the P2X7 receptor, and differential expression of Toll-like receptor-mediated cytokines and defensins, in a Canadian Indigenous group.
Semple C; Choi KG; Kroeker A; Denechezhe L; Orr P; Mookherjee N; Larcombe L
Sci Rep; 2019 Oct; 9(1):14204. PubMed ID: 31578370
[TBL] [Abstract][Full Text] [Related]
2. Human beta-defensin-2 and -3 enhance pro-inflammatory cytokine expression induced by TLR ligands via ATP-release in a P2X7R dependent manner.
Wanke D; Mauch-Mücke K; Holler E; Hehlgans T
Immunobiology; 2016 Nov; 221(11):1259-65. PubMed ID: 27377709
[TBL] [Abstract][Full Text] [Related]
3. TLR activation pathways in HIV-1-exposed seronegative individuals.
Biasin M; Piacentini L; Lo Caputo S; Naddeo V; Pierotti P; Borelli M; Trabattoni D; Mazzotta F; Shearer GM; Clerici M
J Immunol; 2010 Mar; 184(5):2710-7. PubMed ID: 20124101
[TBL] [Abstract][Full Text] [Related]
4. Toll-like receptor agonists partially restore the production of pro-inflammatory cytokines and type I interferon in Sézary syndrome.
Manfrere KC; Torrealba MP; Miyashiro DR; Oliveira LM; de Carvalho GC; Lima JF; Branco AC; Pereira NZ; Pereira J; Sanches JA; Sato MN
Oncotarget; 2016 Nov; 7(46):74592-74601. PubMed ID: 27780938
[TBL] [Abstract][Full Text] [Related]
5. Involvement of purinergic receptors and NOD-like receptor-family protein 3-inflammasome pathway in the adenosine triphosphate-induced cytokine release from macrophages.
Gicquel T; Victoni T; Fautrel A; Robert S; Gleonnec F; Guezingar M; Couillin I; Catros V; Boichot E; Lagente V
Clin Exp Pharmacol Physiol; 2014 Apr; 41(4):279-86. PubMed ID: 24472059
[TBL] [Abstract][Full Text] [Related]
6. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.
Sawaki J; Tsutsui H; Hayashi N; Yasuda K; Akira S; Tanizawa T; Nakanishi K
Int Immunol; 2007 Mar; 19(3):311-20. PubMed ID: 17289654
[TBL] [Abstract][Full Text] [Related]
7. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
8. IL-10 released by concomitant TLR2 stimulation blocks the induction of a subset of Th1 cytokines that are specifically induced by TLR4 or TLR3 in human dendritic cells.
Re F; Strominger JL
J Immunol; 2004 Dec; 173(12):7548-55. PubMed ID: 15585882
[TBL] [Abstract][Full Text] [Related]
9. Effects of various inducers on the expression of P2X7 receptor in human peripheral blood mononuclear cells.
Zhang XJ; Zheng GG; Ma XT; Lin YM; Song YH; Wu KF
Sheng Li Xue Bao; 2005 Apr; 57(2):193-8. PubMed ID: 15830104
[TBL] [Abstract][Full Text] [Related]
10. The dysfunctional innate immune response triggered by Toll-like receptor activation is restored by TLR7/TLR8 and TLR9 ligands in cutaneous lichen planus.
Domingues R; de Carvalho GC; da Silva Oliveira LM; Futata Taniguchi E; Zimbres JM; Aoki V; da Silva Duarte AJ; Sato MN
Br J Dermatol; 2015 Jan; 172(1):48-55. PubMed ID: 24976336
[TBL] [Abstract][Full Text] [Related]
11. CD39 limits P2X7 receptor inflammatory signaling and attenuates sepsis-induced liver injury.
Savio LEB; de Andrade Mello P; Figliuolo VR; de Avelar Almeida TF; Santana PT; Oliveira SDS; Silva CLM; Feldbrügge L; Csizmadia E; Minshall RD; Longhi MS; Wu Y; Robson SC; Coutinho-Silva R
J Hepatol; 2017 Oct; 67(4):716-726. PubMed ID: 28554875
[TBL] [Abstract][Full Text] [Related]
12. Dysregulation of innate immunity in ulcerative colitis patients who fail anti-tumor necrosis factor therapy.
Baird AC; Mallon D; Radford-Smith G; Boyer J; Piche T; Prescott SL; Lawrance IC; Tulic MK
World J Gastroenterol; 2016 Nov; 22(41):9104-9116. PubMed ID: 27895398
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-18 secretion and Th1-like cytokine responses in human peripheral blood mononuclear cells under the influence of the toll-like receptor-5 ligand flagellin.
Bachmann M; Horn K; Poleganov MA; Paulukat J; Nold M; Pfeilschifter J; Mühl H
Cell Microbiol; 2006 Feb; 8(2):289-300. PubMed ID: 16441439
[TBL] [Abstract][Full Text] [Related]
14. Aloe vera downregulates LPS-induced inflammatory cytokine production and expression of NLRP3 inflammasome in human macrophages.
Budai MM; Varga A; Milesz S; Tőzsér J; Benkő S
Mol Immunol; 2013 Dec; 56(4):471-9. PubMed ID: 23911403
[TBL] [Abstract][Full Text] [Related]
15. Purinergic P2X7 receptor expression increases in leukocytes from intra-abdominal septic patients.
Martínez-Banaclocha H; García-Palenciano C; Martínez-Alarcón L; Amores-Iniesta J; Martín-Sánchez F; Ercole GA; González-Lisorge A; Fernández-Pacheco J; Martínez-Gil P; Padilla-Rodríguez J; Baroja-Mazo A; Pelegrín P; Martínez-García JJ
Front Immunol; 2023; 14():1297249. PubMed ID: 38094297
[TBL] [Abstract][Full Text] [Related]
16. Hyper-IgE syndrome is not associated with defects in several candidate toll-like receptor pathway genes.
Hawn TR; Ozinsky A; Williams LM; Rodrigues S; Clark A; Pham U; Hill HR; Ochs H; Aderem A; Liles WC
Hum Immunol; 2005 Jul; 66(7):842-7. PubMed ID: 16112032
[TBL] [Abstract][Full Text] [Related]
17. Autophagy is required for toll-like receptor-mediated interleukin-8 production in intestinal epithelial cells.
Li YY; Ishihara S; Aziz MM; Oka A; Kusunoki R; Tada Y; Yuki T; Amano Y; Ansary MU; Kinoshita Y
Int J Mol Med; 2011 Mar; 27(3):337-44. PubMed ID: 21225224
[TBL] [Abstract][Full Text] [Related]
18. Effect of toll-like receptor (TLR) agonists on TLR and microbicide expression in uterine and vaginal tissues of the mouse.
Soboll G; Schaefer TM; Wira CR
Am J Reprod Immunol; 2006 Jun; 55(6):434-46. PubMed ID: 16674601
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor (TLR) 2-9 agonists-induced cytokines and chemokines: I. Comparison with T cell receptor-induced responses.
Ghosh TK; Mickelson DJ; Fink J; Solberg JC; Inglefield JR; Hook D; Gupta SK; Gibson S; Alkan SS
Cell Immunol; 2006 Sep; 243(1):48-57. PubMed ID: 17250816
[TBL] [Abstract][Full Text] [Related]
20. The Toll-like receptor 2 R753Q mutation modifies cytokine production and Toll-like receptor expression in atopic dermatitis.
Mrabet-Dahbi S; Dalpke AH; Niebuhr M; Frey M; Draing C; Brand S; Heeg K; Werfel T; Renz H
J Allergy Clin Immunol; 2008 Apr; 121(4):1013-9. PubMed ID: 18234309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
